Manta - A Randomized Phase Ii Study Of Fulvestrant In Combination With The Dual Mtor Inhibitor Azd2014 Or Everolimus Or Fulvestrant Alone In Estrogen Receptor-Positive Advanced Or Metastatic Breast Cancer

CANCER RESEARCH(2018)

Cited 17|Views12
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined